US lesion visibility predicts clinically significant upgrade of prostate cancer by systematic biopsy

PURPOSE: To identify predictors of when systematic biopsy leads to a higher overall prostate cancer grade compared to targeted biopsy. METHODS AND MATERIALS: 918 consecutive patients who underwent prostate MRI followed by MRI/US fusion biopsy and systematic biopsies from January 2015 to November 201...

Descripción completa

Detalles Bibliográficos
Autores principales: Velarde, Nathan, Westphalen, Antonio C., Nguyen, Hao G., Neuhaus, John, Shinohara, Katsuto, Simko, Jeffry P., Larson, Peder E., Magudia, Kirti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Pelvis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863714/
https://www.ncbi.nlm.nih.gov/pubmed/34997299
http://dx.doi.org/10.1007/s00261-021-03389-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863714/
https://www.ncbi.nlm.nih.gov/pubmed/34997299
http://dx.doi.org/10.1007/s00261-021-03389-x

Ejemplares similares